Jun
2026
Shanghai New International Expo Center
Visit us
stand E1N32, Pharma Ingredients
Zone

Lisapharma

Exhibitor at CPHI & PMEC China 2026
About Us

Since 1925 Lisapharma is mainly active in the production and development of sterile injectable drugs and it plays an important role in more than 40 countries worldwide. The manufacturing site, based in Erba (Como, Italy), is fully compliant with the GMP requirements. The company is Marketing Authorization Holder in Italy and abroad, of products principally manufactured internally; moreover, Lisapharma is known as a reliable partner of Italian and mutinational companies, for the contract manufacturing activities. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1N32, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • LISATHYONE

    Product LISATHYONE

    ACTIVE PRINCIPLE INGREDIENT: glutathione sodium salt   INDICATONS: prophylaxis of neuropathies following chemoterapy with cisplatin or cisplatin analogues PHARMACEUTICAL FORM - DOSAGE: Powder and solution for injection 600mg/3ml IM - IV PACKAGE: 1 powder vial + 1 solv. ampoule  ...
  • LISAMETHYLE

    Product LISAMETHYLE

    ACTIVE PRINCIPLE INGREDIENT: Methylprednisolone sodium succinate INDICATIONS: Corticosteroid,  anti-inflammatory drug PHARMACEUTICAL FORM - DOSAGE:  20mg/2ml; 40mg/2ml; 120mg/2ml powder and solvent for solution for injection injection IM - IV;  500mg powder for solution for inj...
  • ARFEN

    Product ARFEN

    ACTIVE PRINCIPLE INGREDIENT: ibuprofen lysinate. INDICATIONS: NSAID. Chronic symptomatic treatment of rheumatoid arthritis and osteoarthritis.  PHARMACEUTICAL FORM - DOSAGE: injectable ampoules 3ml - 600mg    PACKAGE: 6 vials/box
  • SUCRATE GEL

    Product SUCRATE GEL

    ACTIVE PRINCIPLE INGREDIENT: Sucralfate gel.INDICATIONS: Gastric ulcer, duodenal ulcer, acute gastritis, symptomatic chronic gastritis, NSAID-related gastric pathologies, reflux esophagitis. PHARMACEUTICAL FORM - DOSAGE - PACKAGE: oral sachets   1g/5ml, 30 sachets/box  -   2...
  • LIKACIN

    Product LIKACIN

    ACTIVE PRINCIPLE INGREDIENT: Amikacin sulfate.INDICATIONS: Semi-synthetic aminoglycoside antibiotic with broad anti- gram positive/gram- negative spectrum.   PHARMACEUTICAL FORM - DOSAGE - PACKAGING: 1 vial 250mg/2ml IM-IV, 1 vial 500mg/2ml IM-IV, 1 vial 1g/4ml IM-IV.  1 vial 250mg/2ml IM...